A collaborative initiative between
Canadian Blood Services
Canadian Institutes of Health Research
and the
CIHR Institute of Circulatory and Respiratory Health
Canadian Blood Services and the Canadian Institutes of Health Research are pleased to announce a joint initiative to fund research in "Blood Utilization and Conservation".
Canadian Blood Services (CBS) is a national, independent, not-for-profit organization whose sole mission is to manage the blood supply in all provinces outside of Quebec. Created in 1998, it is the successor to the Canadian Red Cross Society - Blood Services and the Canadian Blood Agency (the former funding arm of Canada's blood supply system).
Canadian Institutes of Health Research (CIHR) is Canada's premier federal agency for health research. Its objective is to excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improved health for Canadians, more effective health services and products and a strengthened Canadian health care system.
CIHR Institute of Circulatory and Respiratory (ICRH) supports research into causes, mechanisms, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions associated with the heart, lung, brain (stroke), blood, blood vessels, critical care and sleep.
| February 1, 2005 | Registration Deadline |
| March 1, 2005 | Full applications must be courier stamped by this date |
| October 1, 2005 | Anticipated start date |
| August 15, 2005 | Registration Deadline |
| September 15, 2005 | Full applications must be courier stamped by this date |
| April 1, 2006 | Anticipated start date |
The maximum period of support for these grants is three years, and will be based on peer review recommendations.
Introduction
Objectives and Eligible Research Areas
Eligibility
Evaluation Criteria and Process
General CIHR Guidelines and Conditions of Funding
Communications Requirements
How to Apply
Contact Information
CBS and CIHR seek applications for research projects in the general area of blood utilization and conservation.
Blood products and their derivatives include cellular blood components (red blood cells and platelets), plasma products, therapeutic proteins fractionated from plasma, and replacement products for any of these including both recombinant proteins and synthetic materials. Conservation refers to strategies to reduce the use of donor-derived blood products.
Applications could encompass the following areas of research:
Eligibility Criteria
Eligibility criteria for all CIHR research funding programs apply. The business office of the institution of an eligible Nominated Principal Applicant generally administers CIHR funds. Please refer to the Eligibility Requirements for CIHR Grants and Awards regarding the eligibility requirements for individuals and institutions.
Applications will be peer reviewed by the most appropriate peer review committee of CIHR. Applications meeting the research objectives of the program and the scientific standards as determined by peer review will be selected and approved.
Evaluation Process
All personal information collected by CIHR about applicants is used to review applications, to administer and monitor grants and awards, to compile statistics, and to promote and support health research in Canada. Consistent with these purposes, applicants should also expect that information collected by CIHR may be shared as described in Use and Disclosure of Personal Information Provided to CIHR for Peer Review.
Prior to peer review, the appropriate CIHR institute, portfolio and partner representatives may first review proposals for relevance to their strategic interests. The relevance review will be based on the extent to which the proposed research relates to the mandates or strategic priorities of the Institutes, portfolios and partners. As such, representatives will have access to the anonymized project titles and summaries. This review will have no impact on the peer review process.
On completion of the review, the appropriate CIHR institute, portfolio and partner representatives will receive the ranking list, merit scores (ratings) and recommendations of the peer review committee with regards to funding level, for the submitted applications that fall in the fundable range.
A CIHR peer review committee will evaluate the full applications. The committee may be drawn from one of CIHR's pre-existing committees or may be created specifically for this Request for Applications. Committee members are selected based on suggestions from many sources including the institute(s) / portfolio(s) and partner(s), following CIHR's policy on Conflict of Interest, Confidentiality and Privacy Issues in Peer Review. For information on CIHR's peer review process, see Peer Review.
Access to Information Act and Privacy Act, and the Personal Information Protection and Electronic Documents Act (PIPEDA)
CIHR as a federal entity is subject to the Access to Information Act and the Privacy Act, therefore the requirements of these two statutes will apply to all information located in CIHR's premises including, without limitation, cost-sharing agreements related to this Request for Applications and all matters pertaining thereto.
The Parties, while respecting the application of the Privacy Act to federal entities, will also be bound by the PIPEDA. All personal information (as identified by the PIPEDA) collected, used or disclosed in the course of any commercial activity under cost-sharing agreements related to the Request for Applications will be collected, used and disclosed in compliance with the PIPEDA.
All conditions specified in CIHR General Grants and Awards Policies shall apply to applications funded through this Request for Applications. Conditions cover areas such as Applicant and Institutional Responsibilities, Ethics, Official language policy, Access to Information and Privacy Acts, and Acknowledgement of CIHR Support. Successful applicants will be informed of any special financial conditions prior to the release of funds or when they receive CIHR's Authorization for Funding (AFF) document.
Grant recipients are required to acknowledge CIHR, its institutes and partners in any communication or publication related to the project. See CIHR General Grants and Awards Policies, Acknowledgement of CIHR's Support for details on CIHR's communication requirements. The contributing institutes / partners will be identified on the Authorization for Funding and decision letter.
Investigators will be required to provide an annual progress report to CBS. CBS will provide a copy to CIHR for their records.
CBS or CIHR may undertake additional dissemination activities to bring significant published research findings to the attention of health care professionals, health policy or commercial interests. CBS and CIHR will always acknowledge the responsible investigators.
The application process is comprised of two steps: Registration and Full Application.
Review the application instructions provided in How to Apply for a Grant or Award.
Select Operating Grants (Registration and Application) from the Research Funding Programs Application Packages.
Additional instructions must be followed for this RFA:
Send Application by Courier to:
Canadian Institutes of Health Research
Room 97, 160 Elgin Street
Address locator: 4809A
Ottawa, Ontario K1A 0W9
For questions on CIHR funding guidelines, how to apply, and the peer review process contact:
Kelly Fitzpatrick
Program Delivery Officer
Canadian Institutes of Health Research
Telephone: (613) 941-4640
Fax : (613) 954-1800
E-mail: kfitzpatrick@cihr-irsc.gc.ca
